Publication: Leukocyte mitochondrial DNA copy number as a potential biomarker indicating poor outcome in biliary atresia and its association with oxidative DNA damage and telomere length
Issued Date
2019-07-01
Resource Type
ISSN
18728278
15677249
15677249
Other identifier(s)
2-s2.0-85064713967
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Mitochondrion. Vol.47, (2019), 1-9
Suggested Citation
Wanvisa Udomsinprasert, Yong Poovorawan, Voranush Chongsrisawat, Paisarn Vejchapipat, Jiraphun Jittikoon, Sittisak Honsawek Leukocyte mitochondrial DNA copy number as a potential biomarker indicating poor outcome in biliary atresia and its association with oxidative DNA damage and telomere length. Mitochondrion. Vol.47, (2019), 1-9. doi:10.1016/j.mito.2019.04.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/50140
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Leukocyte mitochondrial DNA copy number as a potential biomarker indicating poor outcome in biliary atresia and its association with oxidative DNA damage and telomere length
Other Contributor(s)
Abstract
© 2019 Elsevier B.V. and Mitochondria Research Society Biliary atresia (BA) is a chronic obstructive liver disease, leading to advanced liver failure. Mitochondria dysfunction-mediated aberrant telomere length has been implicated in various pathological processes including cholestasis. Herein, we aimed to investigate associations between mitochondrial DNA (mtDNA) copy number, oxidative DNA damage, telomere length, and disease severity in BA patients. mtDNA copy number and relative telomere length (RTL) were assessed using real-time PCR. Circulating 8-hydroxy-2′-deoxyguanosine (8-OHdG) was measured using ELISA. Our findings showed that BA patients had significantly lower mtDNA copy number and RTL than healthy controls, whereas plasma 8-OHdG levels were significantly elevated in BA patients. mtDNA copy number was remarkably reduced in advanced BA patients. Furthermore, mtDNA copy number was independently associated with age and degree of liver fibrosis in BA patients. Decreased mtDNA copy number was significantly associated with elevated risks of BA, severe fibrosis, jaundice, and hepatic dysfunction. Low mtDNA copy number can be utilized to distinguish patients with poor-outcome from those with good-outcome. Survival curve analysis revealed that low mtDNA copy number was significantly associated with poor survival of BA patients. Interestingly, there was a positive association between mtDNA copy number and plasma 8-OHdG in BA patients, while a negative association of mtDNA copy number with RTL was observed in BA patients. Alternatively, RTL was negatively correlated with plasma 8-OHdG in BA patients. These data demonstrated relationships between leukocytes mtDNA copy number, oxidative stress, telomere length, and clinical parameters in BA patients. Accordingly, our findings indicate that mtDNA copy number may serve as a potential biomarker reflecting BA severity.